Imprese · 17/11/19971 min di lettura
European Research Associates, Ltd. et al.; Withdrawal of Approval of Three New Drug Applications
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is withdrawing approval of three new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.